Nettis, E, Brussino, L, Patella, V, Bonzano, L, Detoraki, A, Di Leo, E, Sirufo, MM, Caruso, C, Lodi Rizzini, F, Conte, M, Yacoub, M-R, Triggiani, M, Ridolo, E, Macchia, L, Rolla, G, Brancaccio, R, De Paulis, A, Spadaro, G, Di Bona, D, D’Uggento, AM, Ginaldi, L, Gaeta, F, Nucera, E, Jaubashi, K, Villalta, D, Dagna, L, Ciotta, D, Pucciarini, F, Bagnasco, D, Celi, G, Chieco Bianchi, F, Cosmi, L, Costantino, MT, Crivellaro, MA, D’Alò, S, Del Biondo, P, Del Giacco, S, Di Gioacchino, M, Di Pietro, L, Favero, E, Gangemi, S, Guarnieri, G, Heffler, E, Leto Barone, MS, Lombardo, C, Losa, F, Matucci, A, Minciullo, PL, Parronchi, P, Passalacqua, G, Pucci, S, Rossi, O, Salvati, L, Schiappoli, M, Senna, G, Vianello, A, Vultaggio, A, Baoran, Y, Incorvaia, C & Canonica, GW 2022, '
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life',
Clinical and Molecular Allergy, vol. 20, pagg. 6-11.
https://doi.org/10.1186/s12948-022-00171-2